Activation and induction of cytosolic phospholipase A2 by TNF-α mediated through Nox2, MAPKs, NF-κB, and p300 in human tracheal smooth muscle cells

Chiang-Wen Lee, Chih-Chung Lin, I-Ta Lee, Hui-Chun Lee, Chuen-Mao Yang

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Cytosolic phospholipase A(2) (cPLA(2)) plays a pivotal role in mediating agonist-induced arachidonic acid (AA) release for prostaglandin (PG) synthesis during inflammation triggered by tumor necrosis factor-α (TNF-α). However, the mechanisms underlying TNF-α-induced cPLA(2) expression and PGE(2) synthesis in human tracheal smooth muscle cells (HTSMCs) remain unknown. Here, we report that TNF-α-induced cPLA(2) protein and mRNA expression, PGE(2) production, and phosphorylation of p42/p44 MAPK, p38 MAPK, and JNK1/2, which were attenuated by pretreatment with a ROS scavenger [N-acetyl-L-cysteine, (NAC)] and the inhibitors of NADPH oxidase [apocynin (APO) and diphenyleneiodonium chloride (DPI)], MEK1/2 (U0126), p38 MAPK (SB202190), and JNK1/2 (SP600125) or transfection with siRNA of Nox2, p47(phox) , MEK1, p42, p38, or JNK2. TNF-α-induced cPLA(2) expression was also inhibited by pretreatment with a selective NF-κB inhibitor [helenalin (HLN)] or transfection with dominant negative mutants of NF-κB inducing kinase (NIK) or IκB kinase (IKK)α/β. TNF-α-induced NF-κB translocation was blocked by pretreatment with NAC, DPI, APO, or HLN, but not by U0126, SB202190, or SP600125. In addition, pretreatment with curcumin (a p300 inhibitor) or transfection with p300 siRNA blocked cPLA(2) expression and PGE(2) synthesis induced by TNF-α. We further confirmed that p300 was associated with the cPLA(2) promoter which was dynamically linked to histone H4 acetylation stimulated by TNF-α, determined by chromatin immunoprecipitation assay. Association of p300 and histone H4 to cPLA(2) promoter was inhibited by U0126, SB202190, and SP600125. These results suggested that in HTSMCs, activation of p47(phox) , MAPKs, NF-κB, and p300 is essential for TNF-α-induced cPLA(2) expression and PGE(2) release.

Original languageEnglish
Pages (from-to)2103-14
Number of pages12
JournalJournal of Cellular Physiology
Volume226
Issue number8
DOIs
Publication statusPublished - Aug 2011
Externally publishedYes

Fingerprint

Cytosolic Phospholipases A2
Phospholipases A
Smooth Muscle Myocytes
Muscle
Tumor Necrosis Factor-alpha
Chemical activation
Cells
Prostaglandins E
Transfection
Acetylcysteine
p38 Mitogen-Activated Protein Kinases
Histones
Small Interfering RNA
Phosphotransferases
Acetylation
Phosphorylation
Curcumin
Mitogen-Activated Protein Kinase 3
NADPH Oxidase
Chromatin Immunoprecipitation

Keywords

  • Acetophenones/pharmacology
  • Acetylation
  • Acetylcysteine/pharmacology
  • Cell Line
  • Curcumin/pharmacology
  • Dinoprostone/biosynthesis
  • E1A-Associated p300 Protein/antagonists & inhibitors
  • Enzyme Inhibitors/pharmacology
  • Free Radical Scavengers/pharmacology
  • Histones/metabolism
  • Humans
  • Membrane Glycoproteins/metabolism
  • Metabolic Networks and Pathways
  • Mitogen-Activated Protein Kinases/antagonists & inhibitors
  • Myocytes, Smooth Muscle/drug effects
  • NADPH Oxidase 2
  • NADPH Oxidases/metabolism
  • NF-kappa B/antagonists & inhibitors
  • Onium Compounds/pharmacology
  • Phospholipases A2/biosynthesis
  • Phosphorylation
  • Sesquiterpenes/pharmacology
  • Trachea/drug effects
  • Tumor Necrosis Factor-alpha/metabolism

Cite this

Activation and induction of cytosolic phospholipase A2 by TNF-α mediated through Nox2, MAPKs, NF-κB, and p300 in human tracheal smooth muscle cells. / Lee, Chiang-Wen; Lin, Chih-Chung; Lee, I-Ta; Lee, Hui-Chun; Yang, Chuen-Mao.

In: Journal of Cellular Physiology, Vol. 226, No. 8, 08.2011, p. 2103-14.

Research output: Contribution to journalArticle

@article{981ce8127d4f41a9bf3524356f784a3c,
title = "Activation and induction of cytosolic phospholipase A2 by TNF-α mediated through Nox2, MAPKs, NF-κB, and p300 in human tracheal smooth muscle cells",
abstract = "Cytosolic phospholipase A(2) (cPLA(2)) plays a pivotal role in mediating agonist-induced arachidonic acid (AA) release for prostaglandin (PG) synthesis during inflammation triggered by tumor necrosis factor-α (TNF-α). However, the mechanisms underlying TNF-α-induced cPLA(2) expression and PGE(2) synthesis in human tracheal smooth muscle cells (HTSMCs) remain unknown. Here, we report that TNF-α-induced cPLA(2) protein and mRNA expression, PGE(2) production, and phosphorylation of p42/p44 MAPK, p38 MAPK, and JNK1/2, which were attenuated by pretreatment with a ROS scavenger [N-acetyl-L-cysteine, (NAC)] and the inhibitors of NADPH oxidase [apocynin (APO) and diphenyleneiodonium chloride (DPI)], MEK1/2 (U0126), p38 MAPK (SB202190), and JNK1/2 (SP600125) or transfection with siRNA of Nox2, p47(phox) , MEK1, p42, p38, or JNK2. TNF-α-induced cPLA(2) expression was also inhibited by pretreatment with a selective NF-κB inhibitor [helenalin (HLN)] or transfection with dominant negative mutants of NF-κB inducing kinase (NIK) or IκB kinase (IKK)α/β. TNF-α-induced NF-κB translocation was blocked by pretreatment with NAC, DPI, APO, or HLN, but not by U0126, SB202190, or SP600125. In addition, pretreatment with curcumin (a p300 inhibitor) or transfection with p300 siRNA blocked cPLA(2) expression and PGE(2) synthesis induced by TNF-α. We further confirmed that p300 was associated with the cPLA(2) promoter which was dynamically linked to histone H4 acetylation stimulated by TNF-α, determined by chromatin immunoprecipitation assay. Association of p300 and histone H4 to cPLA(2) promoter was inhibited by U0126, SB202190, and SP600125. These results suggested that in HTSMCs, activation of p47(phox) , MAPKs, NF-κB, and p300 is essential for TNF-α-induced cPLA(2) expression and PGE(2) release.",
keywords = "Acetophenones/pharmacology, Acetylation, Acetylcysteine/pharmacology, Cell Line, Curcumin/pharmacology, Dinoprostone/biosynthesis, E1A-Associated p300 Protein/antagonists & inhibitors, Enzyme Inhibitors/pharmacology, Free Radical Scavengers/pharmacology, Histones/metabolism, Humans, Membrane Glycoproteins/metabolism, Metabolic Networks and Pathways, Mitogen-Activated Protein Kinases/antagonists & inhibitors, Myocytes, Smooth Muscle/drug effects, NADPH Oxidase 2, NADPH Oxidases/metabolism, NF-kappa B/antagonists & inhibitors, Onium Compounds/pharmacology, Phospholipases A2/biosynthesis, Phosphorylation, Sesquiterpenes/pharmacology, Trachea/drug effects, Tumor Necrosis Factor-alpha/metabolism",
author = "Chiang-Wen Lee and Chih-Chung Lin and I-Ta Lee and Hui-Chun Lee and Chuen-Mao Yang",
note = "Copyright {\circledC} 2010 Wiley-Liss, Inc.",
year = "2011",
month = "8",
doi = "10.1002/jcp.22537",
language = "English",
volume = "226",
pages = "2103--14",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Activation and induction of cytosolic phospholipase A2 by TNF-α mediated through Nox2, MAPKs, NF-κB, and p300 in human tracheal smooth muscle cells

AU - Lee, Chiang-Wen

AU - Lin, Chih-Chung

AU - Lee, I-Ta

AU - Lee, Hui-Chun

AU - Yang, Chuen-Mao

N1 - Copyright © 2010 Wiley-Liss, Inc.

PY - 2011/8

Y1 - 2011/8

N2 - Cytosolic phospholipase A(2) (cPLA(2)) plays a pivotal role in mediating agonist-induced arachidonic acid (AA) release for prostaglandin (PG) synthesis during inflammation triggered by tumor necrosis factor-α (TNF-α). However, the mechanisms underlying TNF-α-induced cPLA(2) expression and PGE(2) synthesis in human tracheal smooth muscle cells (HTSMCs) remain unknown. Here, we report that TNF-α-induced cPLA(2) protein and mRNA expression, PGE(2) production, and phosphorylation of p42/p44 MAPK, p38 MAPK, and JNK1/2, which were attenuated by pretreatment with a ROS scavenger [N-acetyl-L-cysteine, (NAC)] and the inhibitors of NADPH oxidase [apocynin (APO) and diphenyleneiodonium chloride (DPI)], MEK1/2 (U0126), p38 MAPK (SB202190), and JNK1/2 (SP600125) or transfection with siRNA of Nox2, p47(phox) , MEK1, p42, p38, or JNK2. TNF-α-induced cPLA(2) expression was also inhibited by pretreatment with a selective NF-κB inhibitor [helenalin (HLN)] or transfection with dominant negative mutants of NF-κB inducing kinase (NIK) or IκB kinase (IKK)α/β. TNF-α-induced NF-κB translocation was blocked by pretreatment with NAC, DPI, APO, or HLN, but not by U0126, SB202190, or SP600125. In addition, pretreatment with curcumin (a p300 inhibitor) or transfection with p300 siRNA blocked cPLA(2) expression and PGE(2) synthesis induced by TNF-α. We further confirmed that p300 was associated with the cPLA(2) promoter which was dynamically linked to histone H4 acetylation stimulated by TNF-α, determined by chromatin immunoprecipitation assay. Association of p300 and histone H4 to cPLA(2) promoter was inhibited by U0126, SB202190, and SP600125. These results suggested that in HTSMCs, activation of p47(phox) , MAPKs, NF-κB, and p300 is essential for TNF-α-induced cPLA(2) expression and PGE(2) release.

AB - Cytosolic phospholipase A(2) (cPLA(2)) plays a pivotal role in mediating agonist-induced arachidonic acid (AA) release for prostaglandin (PG) synthesis during inflammation triggered by tumor necrosis factor-α (TNF-α). However, the mechanisms underlying TNF-α-induced cPLA(2) expression and PGE(2) synthesis in human tracheal smooth muscle cells (HTSMCs) remain unknown. Here, we report that TNF-α-induced cPLA(2) protein and mRNA expression, PGE(2) production, and phosphorylation of p42/p44 MAPK, p38 MAPK, and JNK1/2, which were attenuated by pretreatment with a ROS scavenger [N-acetyl-L-cysteine, (NAC)] and the inhibitors of NADPH oxidase [apocynin (APO) and diphenyleneiodonium chloride (DPI)], MEK1/2 (U0126), p38 MAPK (SB202190), and JNK1/2 (SP600125) or transfection with siRNA of Nox2, p47(phox) , MEK1, p42, p38, or JNK2. TNF-α-induced cPLA(2) expression was also inhibited by pretreatment with a selective NF-κB inhibitor [helenalin (HLN)] or transfection with dominant negative mutants of NF-κB inducing kinase (NIK) or IκB kinase (IKK)α/β. TNF-α-induced NF-κB translocation was blocked by pretreatment with NAC, DPI, APO, or HLN, but not by U0126, SB202190, or SP600125. In addition, pretreatment with curcumin (a p300 inhibitor) or transfection with p300 siRNA blocked cPLA(2) expression and PGE(2) synthesis induced by TNF-α. We further confirmed that p300 was associated with the cPLA(2) promoter which was dynamically linked to histone H4 acetylation stimulated by TNF-α, determined by chromatin immunoprecipitation assay. Association of p300 and histone H4 to cPLA(2) promoter was inhibited by U0126, SB202190, and SP600125. These results suggested that in HTSMCs, activation of p47(phox) , MAPKs, NF-κB, and p300 is essential for TNF-α-induced cPLA(2) expression and PGE(2) release.

KW - Acetophenones/pharmacology

KW - Acetylation

KW - Acetylcysteine/pharmacology

KW - Cell Line

KW - Curcumin/pharmacology

KW - Dinoprostone/biosynthesis

KW - E1A-Associated p300 Protein/antagonists & inhibitors

KW - Enzyme Inhibitors/pharmacology

KW - Free Radical Scavengers/pharmacology

KW - Histones/metabolism

KW - Humans

KW - Membrane Glycoproteins/metabolism

KW - Metabolic Networks and Pathways

KW - Mitogen-Activated Protein Kinases/antagonists & inhibitors

KW - Myocytes, Smooth Muscle/drug effects

KW - NADPH Oxidase 2

KW - NADPH Oxidases/metabolism

KW - NF-kappa B/antagonists & inhibitors

KW - Onium Compounds/pharmacology

KW - Phospholipases A2/biosynthesis

KW - Phosphorylation

KW - Sesquiterpenes/pharmacology

KW - Trachea/drug effects

KW - Tumor Necrosis Factor-alpha/metabolism

UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-79955097685&origin=resultslist&sort=plf-f&src=s&sid=524e10ee16fe74abb601c2c0ccd235cd&sot=autdocs&sdt=autdocs&sl=18&s=AU-ID%2835196417900%29&relpos=50&citeCnt=41&searchTerm=

UR - https://www.scopus.com/results/citedbyresults.uri?sort=plf-f&cite=2-s2.0-79955097685&src=s&imp=t&sid=8913925f2a96e6474fec0f6e86ed7a8e&sot=cite&sdt=a&sl=0&origin=recordpage&editSaveSearch=&txGid=36d3e6f5c63943b2c616a522a044ffdc

U2 - 10.1002/jcp.22537

DO - 10.1002/jcp.22537

M3 - Article

VL - 226

SP - 2103

EP - 2114

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 8

ER -